Health Programmes

EQUIP Project

Programme Title

Extending Quality Improvement for HIV/AIDS (EQUIP) project
Funding Cycle: October 2014 to September 2019

Project Description

The Extending Quality Improvement for HIV/AIDS (EQUIP) project is a multi-country project aimed at strengthening HIV treatment and prevention to support universal access and coverage in 18 countries. EQUIP supports USAID’s commitment under PEPFAR 3.0 to impact the global burden of HIV/AIDS by fast-tracking cost-effective treatment and prevention initiatives to bring the HIV epidemic under control. The EQUIP rapid-response mechanism was established as a consortium of five African-based partners (Right to Care, Kheth’Impilo, MAtCH, ANOVA and Partners in Hope) tasked with the development, testing and proving of innovative concepts that can be scaled-up globally through 3 key outcomes: (i) Increased new on treatment through targeted testing and rapid scale-up of Test & Start strategies, (ii) Retained in care and virally suppressed applying differentiated models of treatment distribution and viral load scale-up (iii) Costing of health interventions and outcomes.

Geographical location:

Kheth’Impilo provide technical support to Zimbabwe, Burundi, DRC and Nigeria.
In Zimbabwe, OPHID, FHI 360 and PSI as the Implementing Partners supported by the USAID Mission and the Ministry of Health and Child Care (MOHCC).

In Burundi, FHI 360, ASSIST, MSH, JSI, MEASURE and PATHFINDER as implementing partners and supported by the USAID Mission and the Ministry of Health.

In the DRC KI EQUIP is working with ProVic+ IHP as the implementing partner and supported by the local USAID Mission and the Department of Health.

The program is in the infancy state in Nigeria. We are working with the Federal Ministry of Health to identify the implementing partners we will be working with.

a) Burundi

KI Equip supported the Re-focused testing on high yield approaches in hospitals by introducing testing in patient wards. 1078 pre-ART patients were identified for linkage to anti-retroviral treatment. 21 Ministry of Health facility staff were mentored on monitoring and interpretation of viral load results to improve clinical outcomes. KI supported the establishment of community ART delivery for 527 clients in 8 points of distribution.

b) DRC

KI EQUIP conducted readiness capacity assessment for Test and Start (TS), followed by mentoring and coaching on the initiation and implementation in 71 out of 96 facilities (translating to 73 % achievement). 948 patients were enrolled in MMSD at facility level and 3 points of distribution of ART (PODI House) were established with 1,038 patients enrolled. To optimize and scale up of patient viral load monitoring, KI EQUIP supported 10,859 VL sample collection for testing. 4,624 results were received and 3,307 (71.5%) virological suppression recorded

c) Nigeria

KI EQUIP and PEPFAR teams had their first introductory meetings with the National Coordinator and the Unit Leads of the National AIDS and Sexually Transmitted Diseases Control Program (NASCAP) to define the work-streams (HIVST, Support for DMOC, Viral Load Scale Up). Draft Protocol for HIV Self Testing was developed and shared with Partners. Facility assessments was conducted on Test and Start, Pharmaceutical Service delivery, Differentiated model of ART delivery, Viral load monitoring and Monitoring and Evaluation services.

Differentiated Models of Treatment provision was conducted for 8 implementing partners and FMOH representative with the aim of assisting the DoH to get a better overview of the models being implemented by the various implementing partners

d) Zimbabwe

KI EQUIP conducted assessments/Site profiling for MMD outside the facilities (CARGs) in 35 out of 42 facilities targeted for the year (translating to 83% achievement. High yield testing assessments was completed in 47 of the 73 yearly target (64% achievement). Protocol and costing tools for the MMD was developed and submitted to the Medical Research Council of Zimbabwe (MRCZ) while an automated ABBOT viral load machine was purchased and placed at PSI center in Chitungwiza for the Chitungwiza Viral Load Demonstration Project